Smith & Nephew SNATS Inc. Company Profile
NYSE: SNNHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Smith & Nephew SNATS at a glance
Smith & Nephew SNATS Inc. (NYSE: SNN) is a Medical Devices company in the Healthcare sector headquartered in Watford, United Kingdom. Smith & Nephew SNATS is led by Dr. Deepak S. Nath Ph.D. and employs about 17,000 people. At a market capitalization of $11.26 billion, it is considered a large-cap company.
Its SEC Central Index Key (CIK) is 0000845982, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Smith & Nephew SNATS do?
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Business description based on the company's public filings.
Company information
- Legal name
- Smith & Nephew SNATS Inc.
- Ticker
- NYSE: SNN
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Dr. Deepak S. Nath Ph.D.
- Employees
- 17,000
- Headquarters
- Building 5, Watford, United Kingdom
- Phone
- 44 1923 477 100
- Website
- smith-nephew.com
- Market cap
- $11.26B
- SEC CIK
- 0000845982
Companies similar to Smith & Nephew SNATS
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TXG10x Genomics Inc. Class A | 77.28 | +1.55% | $10.07B | vs SNN |
| BIO.BBio-Rad Laboratories Inc. | 365.08 | 0.00% | $9.76B | vs SNN |
| GKOSGlaukos Corporation | 161.29 | -6.32% | $9.51B | vs SNN |
| TMDXTransMedics Group Inc. | 79.00 | -2.55% | $2.74B | vs SNN |
| ENOVEnovis Corporation | 17.43 | -1.02% | $1.01B | vs SNN |
| LMRILumexa Imaging Holdings Inc. | 10.33 | -2.46% | $992.45M | vs SNN |
| DCTHDelcath Systems Inc. | 15.04 | -2.21% | $521.87M | vs SNN |
| TLSITriSalus Life Sciences Inc. | 4.13 | -2.82% | $254.30M | vs SNN |